feed,title,long_url,short_url
Benzinga,CTI BioPharma's Pacritinib Demonstrates Positive Safety Profile In Graft-Versus-Host-Disease Study,https://benzinga.com/general/biotech/21/03/20280345/cti-biopharmas-pacritinib-demonstrates-positive-safety-profile-in-graft-versus-host-disease-study,https://j.mp/3lIbqYS
